These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Host-pathogen interplay in the respiratory environment of cystic fibrosis. Yonker LM; Cigana C; Hurley BP; Bragonzi A J Cyst Fibros; 2015 Jul; 14(4):431-439. PubMed ID: 25800687 [TBL] [Abstract][Full Text] [Related]
9. Digging through the Obstruction: Insight into the Epithelial Cell Response to Respiratory Virus Infection in Patients with Cystic Fibrosis. Hendricks MR; Bomberger JM J Virol; 2016 May; 90(9):4258-4261. PubMed ID: 26865718 [TBL] [Abstract][Full Text] [Related]
10. Lung inflammation early in cystic fibrosis: bugs are indicted, but the defense is guilty. Berger M Am J Respir Crit Care Med; 2002 Apr; 165(7):857-8. PubMed ID: 11934707 [No Abstract] [Full Text] [Related]
11. Understanding the Entanglement: Neutrophil Extracellular Traps (NETs) in Cystic Fibrosis. Martínez-Alemán SR; Campos-García L; Palma-Nicolas JP; Hernández-Bello R; González GM; Sánchez-González A Front Cell Infect Microbiol; 2017; 7():104. PubMed ID: 28428948 [TBL] [Abstract][Full Text] [Related]
12. Local humoral immunity and immune reactions in the lungs of patients with cystic fibrosis. Schiøtz PO Acta Pathol Microbiol Scand Suppl; 1981; 276():1-25. PubMed ID: 6951389 [No Abstract] [Full Text] [Related]
13. IL-17 in cystic fibrosis: more than just Th17 cells. Dubin PJ; Kolls JK Am J Respir Crit Care Med; 2011 Jul; 184(2):155-7. PubMed ID: 21765030 [No Abstract] [Full Text] [Related]
14. Incapacitating the immune system in cystic fibrosis. Sabroe I; Whyte MK Nat Med; 2007 Dec; 13(12):1417-8. PubMed ID: 18064033 [No Abstract] [Full Text] [Related]
15. Mechanisms of Changes in Immune Response during Bacterial Coinfections of the Respiratory Tract. Sviriaeva EN; Korneev KV; Drutskaya MS; Kuprash DV Biochemistry (Mosc); 2016 Nov; 81(11):1340-1349. PubMed ID: 27914459 [TBL] [Abstract][Full Text] [Related]
16. Glucosylceramide Critically Contributes to the Host Defense of Cystic Fibrosis Lungs. Kovacic B; Sehl C; Wilker B; Kamler M; Gulbins E; Becker KA Cell Physiol Biochem; 2017; 41(3):1208-1218. PubMed ID: 28427052 [TBL] [Abstract][Full Text] [Related]
17. Detection of viral and bacterial respiratory pathogens in patients with cystic fibrosis. Stelzer-Braid S; Johal H; Skilbeck K; Steller A; Alsubie H; Tovey E; Van Asperen P; McKay K; Rawlinson WD J Virol Methods; 2012 Dec; 186(1-2):109-12. PubMed ID: 22940004 [TBL] [Abstract][Full Text] [Related]
18. [Viral diseases of the respiratory system -- morphogenetic aspects of pulmonary lesions]. Schaefer HE Verh Dtsch Ges Pathol; 1981; 65():107-27. PubMed ID: 7347449 [No Abstract] [Full Text] [Related]
19. The innate immune system in cystic fibrosis lung disease. Bals R; Weiner DJ; Wilson JM J Clin Invest; 1999 Feb; 103(3):303-7. PubMed ID: 9927489 [No Abstract] [Full Text] [Related]
20. Essential fatty acid deficiency in the rabbit as a model of nutritional impairment in cystic fibrosis. In vitro and in vivo effects on lung defense mechanisms. Harper TB; Chase HP; Henson J; Henson PM Am Rev Respir Dis; 1982 Sep; 126(3):540-7. PubMed ID: 7125341 [No Abstract] [Full Text] [Related] [Next] [New Search]